Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on MedAdvisor.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Forget surgery, Orthocell says tennis elbow can be fixed with its tendon cell therapy
Health & Biotech
ASX Health Stocks: Amplia’s pancreatic cancer trial gets boost; Emyria’s MDMA therapy is one step closer
Tech
Analysts say these ASX small cap tech stocks are pursuing their next growth phase
News
Market Highlights: US tech stocks rally, dividends at all-time high, and 5 ASX small caps to watch today
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Why Salter Brothers is eyeing ASX small cap medtechs
News
Top 10 at 10: Which ASX exploration stocks are hitting paydirt today?
News
Market Highlights: Oh, BoJ, what have you done… and 5 ASX small caps to watch today
Experts
MoneyTalks: 3 ‘below-the-radar’ ASX stocks to watch in the second half of 2022
Health & Biotech
ASX Health Stocks: Antisense says ATL1102 could be effective in rare genetic muscle disease
News
Trading Places: BGH ups Virtus stake to above 50pc as battle for fertility company escalates
Health & Biotech
ASX Health Stocks: Rhythm Bio surprises with major announcement on ColoSTAT
Health & Biotech
Check Up: The future of telehealth, and the best and worst performing ASX health stocks for the month
Health & Biotech
ASX Health Stocks: Results show revenue is growing in first half, but profitability still elusive
Health & Biotech
ASX Health Stocks: Health app MedAdvisor maintains guidance, but share price slips 5pc
News
Reporting Season Round Up: Leading the charge was Playside – the ASX’s local games developer
Experts
